Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,227,791
-$144,703 QoQ
Shares Held
50,988
+4.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#1,200
of 2,821 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Probity Advisors, Inc. holds $17,628,696 across 10 Drug Manufacturers - General names. PFE ranks #7 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,714 | $3,255,253 | |
| 2 | ABBV |
AbbVie Inc.
|
12,209 | $3,072,272 | |
| 3 | MRK |
Merck & Co., Inc.
|
19,934 | $2,561,519 | |
| 4 | JNJ |
Johnson & Johnson
|
9,274 | $2,355,317 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,128 | $1,532,251 | |
| 6 | GSK |
GSK plc
|
24,377 | $1,277,842 | |
| 7 | PFE |
Pfizer Inc
This page
|
50,988 | $1,227,791 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
20,006 | $1,152,745 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,227,791 | 50,988 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,372,494 | 48,878 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,115,520 | 44,800 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,242,404 | 48,760 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,204,703 | 49,699 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,049,861 | 41,431 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,061,412 | 40,008 | Shares | Sole | 2025-03-05 | |
| 2024-09-30 | $1,180,173 | 40,780 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $1,052,187 | 37,605 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $964,423 | 34,754 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,001,517 | 34,787 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,193,323 | 35,976 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,238,536 | 33,766 | Shares | Sole | 2023-08-10 | |
| 2022-12-31 | $1,766,857 | 34,482 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,537,376 | 35,132 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,962,612 | 37,433 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,976,630 | 38,181 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,444,670 | 41,400 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,804,269 | 41,950 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $1,609,710 | 41,106 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,498,074 | 41,349 | Shares | Sole | 2021-04-28 | |
| 2020-09-30 | $1,448,217 | 39,461 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,306,366 | 39,950 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,274,263 | 39,040 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||